Back to Search
RAKESH BERI, PHARM.D.
PHARM.D.
Oncology Pharmacist
NPI: 1003991001Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen.
PMID 19543331·Bone Marrow Transplant·2010
4-observational
Severe dermatologic reactions at multiple sites after paclitaxel administration.
PMID 14742758·Ann Pharmacother·2004
5-case
Issues associated with assessing nuclear localization of N-terminally unphosphorylated beta-catenin with monoclonal antibody 8E7.
PMID 19187541·Biol Direct·2009
7-preclinical
Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
PMID 19181929·Int Immunol·2009
8-other
A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils.
PMID 18837743·Eur J Clin Invest·2008
4-observational
Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
PMID 18840018·Drug Saf·2008
1-meta
Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?
PMID 18264144·Bone Marrow Transplant·2008
3-trial
Treatment with antisense oligonucleotide reduces the expression of type I collagen in a human-skin organ-wound model: implications for antifibrotic gene therapy.
PMID 18046156·Ann Plast Surg·2007
8-other
Endothelial cells' activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: relevance to the pathogenesis of atherosclerosis.
PMID 17534423·PLoS One·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 833 S WOOD ST
CHICAGO, IL 60612 - Phone
- (312) 996-0870
Quick Facts
- NPI
- 1003991001
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile